Upregulation of ANKRD13D may affect endocytic trafficking of EGFR by inhibition of its ubiquitinated form from the cell surface, attenuating pro-proliferative signaling of internalized EGFR [59], potentially aggravating AAA. Here, ANKRD13D is linked to triple-A syndrome.